Policies & Disclaimers  |  Contact Us  |  Site Map  |  Important Safety Information   
Inhaled Ventavis® (iloprost) Inhalation Solution Breathe In the Power of Prostacyclin In Pulmonary Arterial Hypertension (PAH) NYHA Class III or IV
     PAH Pathways
PAH Pathways - Actelion Services & Support
Download 20 mcg/mL Medication Order Form
Download the
Ventavis Patient
Enrollment Forms

PAH Pathways™

Your patients are automatically enrolled in the PAH Pathways program when you prescribe Ventavis® (iloprost) Inhalation Solution. They are contacted by our Pathways counselors and our specialty pharmacy nurses in order to handle reimbursement and Ventavis dosage and administration training.

For more information on how PAH Pathways works for your patients, make an appointment with one of our representatives.

  • Insurance help: Your patient's PAH Pathways counselor will verify insurance coverage and clarify the co-payment amount before the prescription is filled.
  • Financial Assistance: Actelion sponsors some financial assistance programs for eligible patients; others are available through alternative sources. PAH Pathways can help your patients find and apply for the appropriate program or programs available to them.
  • Access to therapy: Once benefits are verified, we will arrange for delivery of the medication directly to your patient's home.


* In the AIR pivotal trial, Ventavis delivered significant patient improvement in a composite endpoint consisting of ≥10% increase in 6MWD, improvement in NYHA functional class, and lack of deterioration or death (p=0.0033).

IMPORTANT SAFETY INFORMATION:
In clinical studies, common adverse reactions due to Ventavis included vasodilation (flushing), cough, headache, trismus, and insomnia. Serious adverse events reported at a rate of less than 3% included congestive heart failure, chest pain, supraventricular tachycardia, dyspnea, peripheral edema, and kidney failure. Vital signs should be monitored while initiating Ventavis. Ventavis should not be initiated in patients with systolic blood pressure less than 85 mmHg. Stop Ventavis immediately if signs of pulmonary edema occur; this may be a sign of pulmonary venous hypertension.

Please see full Prescribing Information

For more information about
Ventavis, please call
1-866-ACTELION (1-866-228-3546).

Policies & Disclaimers  |  Contact Us  |  Site Map  |  Important Safety Information

THIS SITE IS INTENDED FOR U.S. AUDIENCES ONLY.
SECOND WIND is a licensed trademark of Pulmonary Rehabilitation Associates.
©2010 Actelion Pharmaceuticals US, Inc. All rights reserved.

ACTELION